MAC Clinical Research   Report issue

For profit Phase 1 Phase 2
Founded: Blackpool United Kingdom (2002)

Organization Overview

First Clinical Trial
2012
NCT01626391
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

MAC Clinical Research | MAC Clinical Research Early Phase Unit | MAC Clinical Research, United Kingdom

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alzheimer Disease (Phase 2)

Arthritis (Phase 1)

Arthritis, Psoriatic (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 9
  • # of Trial APIs: 11